IL164826A0 - Methods for the treatment of respiratory diseases and conditions using a selective inos inhibitor - Google Patents

Methods for the treatment of respiratory diseases and conditions using a selective inos inhibitor

Info

Publication number
IL164826A0
IL164826A0 IL16482603A IL16482603A IL164826A0 IL 164826 A0 IL164826 A0 IL 164826A0 IL 16482603 A IL16482603 A IL 16482603A IL 16482603 A IL16482603 A IL 16482603A IL 164826 A0 IL164826 A0 IL 164826A0
Authority
IL
Israel
Prior art keywords
treatment
conditions
methods
respiratory diseases
inos inhibitor
Prior art date
Application number
IL16482603A
Other languages
English (en)
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of IL164826A0 publication Critical patent/IL164826A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
IL16482603A 2002-05-16 2003-05-16 Methods for the treatment of respiratory diseases and conditions using a selective inos inhibitor IL164826A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38105402P 2002-05-16 2002-05-16
PCT/US2003/015369 WO2003097163A2 (en) 2002-05-16 2003-05-16 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions

Publications (1)

Publication Number Publication Date
IL164826A0 true IL164826A0 (en) 2005-12-18

Family

ID=29550060

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16482603A IL164826A0 (en) 2002-05-16 2003-05-16 Methods for the treatment of respiratory diseases and conditions using a selective inos inhibitor

Country Status (13)

Country Link
US (1) US20040077639A1 (zh)
EP (1) EP1506040A2 (zh)
JP (1) JP2005536467A (zh)
KR (1) KR20050004155A (zh)
CN (1) CN1652843A (zh)
AU (1) AU2003234606A1 (zh)
BR (1) BR0311180A (zh)
CA (1) CA2486061A1 (zh)
IL (1) IL164826A0 (zh)
MX (1) MXPA04011404A (zh)
PL (1) PL373952A1 (zh)
WO (1) WO2003097163A2 (zh)
ZA (1) ZA200408905B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408182A (pt) * 2003-03-11 2006-03-21 Pharmacia Corp sal cristalino monoidrato de salicilato de s-[2-[(1-iminoetil)amino]etil]-2-metil-l-cisteìna
BRPI0408177A (pt) * 2003-03-11 2006-03-01 Pharmacia Corp sal cristalino de maleato de s-[2-[(1-iminoetil)amino]etil]-2-metil-l-cisteìna de forma ii
CN101068559B (zh) * 2004-07-23 2011-08-31 福生生物科技股份有限公司 红球姜的抗超敏炎症和抗敏活性
TWI375671B (en) * 2010-03-01 2012-11-01 Univ China Medical Pharmaceutical compositions containing brazilin for inhibiting expression of cytokines of t helper cell type ii and/or inhibiting expression of chemokines and uses of the same
EP2591777B1 (de) * 2010-07-09 2016-12-14 Justus-Liebig-Universität Gießen L-NIL als Inhibitor zur Regeneration der Lunge von an COPD leidenden Patienten
JP7334979B2 (ja) 2017-09-12 2023-08-29 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ イソプレニルシステインカルボキシルメチルトランスフェラーゼ阻害剤として有用な化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262784B1 (en) * 1993-06-01 2001-07-17 Samsung Electronics Co., Ltd Active matrix display devices having improved opening and contrast ratios and methods of forming same and a storage electrode line
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
US6331543B1 (en) * 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US6333354B1 (en) * 1997-02-28 2001-12-25 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of PDE inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
GB9811599D0 (en) * 1998-05-30 1998-07-29 Glaxo Group Ltd Nitric oxide synthase inhibitors
ZA200206459B (en) * 2000-03-24 2003-08-13 Pharmacia Corp Amidino compound and salts thereof useful as nitric oxide synthase inhibitors.
US6545170B2 (en) * 2000-04-13 2003-04-08 Pharmacia Corporation 2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
EP1305293A1 (en) * 2000-08-01 2003-05-02 Pharmacia Corporation Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
AR031609A1 (es) * 2000-09-15 2003-09-24 Pharmacia Corp Derivados de acido 2-amino-2-alquil-3 heptenoico y heptinoico utiles como inhibidores de oxido nitrico sintetasa
AR035585A1 (es) * 2000-09-15 2004-06-16 Pharmacia Corp Derivados del acido 2-amino-2-alquil-4-heptenoico, composicion farmaceutica y su uso en la fabricacion de medicamentos
TWI290130B (en) * 2000-09-15 2007-11-21 Pharmacia Corp 2-Amino-2alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors

Also Published As

Publication number Publication date
WO2003097163A2 (en) 2003-11-27
WO2003097163A3 (en) 2004-10-21
AU2003234606A1 (en) 2003-12-02
EP1506040A2 (en) 2005-02-16
CN1652843A (zh) 2005-08-10
JP2005536467A (ja) 2005-12-02
PL373952A1 (en) 2005-09-19
MXPA04011404A (es) 2005-02-14
KR20050004155A (ko) 2005-01-12
CA2486061A1 (en) 2003-11-27
BR0311180A (pt) 2005-03-01
US20040077639A1 (en) 2004-04-22
ZA200408905B (en) 2006-06-28

Similar Documents

Publication Publication Date Title
AU2003256253A8 (en) Aerosol for medical treatment and methods
HK1081173A1 (en) Phenethanolamine derivative for the treatment of respiratory diseases
HK1066479A1 (en) Phenethanolamine derivatives for treatment of respiratory diseases
IL157149A0 (en) Phenethanolamine derivatives for treatment of respiratory diseases
EP1509279A4 (en) DEVICE AND METHOD FOR THE TREATMENT OF HEART DISEASES
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003210428A1 (en) Phenethanolamine derivatives for treatment of respiratory diseases
AU2003232148A8 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
AU2003299378A8 (en) Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases
GB0004531D0 (en) The treatment of respiratory diseases
IL164826A0 (en) Methods for the treatment of respiratory diseases and conditions using a selective inos inhibitor
AU2003302323A8 (en) A method and therapeutic platelets
EP1389129A4 (en) METHOD FOR TREATING RESPIRATORY DISEASES
GB0208897D0 (en) New method of treatment
GB0205069D0 (en) Fluid treatment apparatus and a method of use thereof
EP1569928A4 (en) THERAPEUTIC COMPOUNDS AND METHOD
AU2003223094A8 (en) Hand held device for inhalation therapy and method of use thereof
GB0221712D0 (en) Methods of treatment
PL373000A1 (en) Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
AU2002328905A1 (en) A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method
EP1488800A4 (en) MEDICINE FOR THE TREATMENT OF PROTOCOL DISEASES
GB0213198D0 (en) Method of treatment
EP1511474A4 (en) Methods of Treatment
GB0224330D0 (en) Treatment of respiratory disorders